← Return to Help Finding Clinical Trials

Discussion

Help Finding Clinical Trials

Pancreatic Cancer | Last Active: Sep 5, 2023 | Replies (58)
Comment receiving replies
@stageivsurvivor

The trial was RucaPANC for maintenance monotherapy and targeted BRCA1, BRCA2, PALB2 mutations using the PARP-1 inhibitor Rucaparib (Rubraca).

More details on the trial-

PARP STUDY AT PennMedicine

https://ascopubs.org/doi/10.1200/PO.17.00316https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6057747/

This is a YouTube video of my case by pancreatic cancer oncologist Dr. Kim Reiss-Binder at PennMedicine. It starts at time stamp 1:00 and the conclusion is at the end of the presentation.

Jump to this post

Replies to "The trial was RucaPANC for maintenance monotherapy and targeted BRCA1, BRCA2, PALB2 mutations using the PARP-1..."
pendesk8 | @pendesk8 | Dec 24, 2022

thank you .

VIEW AND REPLY
gardenlady1116 | @gardenlady1116 | Mar 4, 2023

Outstanding!!!!!! I will send to family members with BRCA1.

VIEW AND REPLY
pendesk8 | @pendesk8 | May 25, 2023

I am going to NCI in bethesda ,Md in june for screening for a clinical trial for my ATM gene mutation.

VIEW AND REPLY